State Street Corp Acadia Pharmaceuticals Inc Transaction History

State Street Corp

$2.41 Trillion
Q3 2024

A detailed history of State Street Corp transactions in Acadia Pharmaceuticals Inc stock. As of the latest transaction made, State Street Corp holds 5,973,874 shares of ACAD stock, worth $97.2 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

5,973,874

Previous 5,800,790 2.98%

Holding current value

$97.2 Million

Previous $94.3 Million 2.47%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$15.14 - $19.14 $2.62 Million - $3.31 Million	173,084 Added 2.98%	5,973,874 $91.9 Million
Q2 2024 Aug 14, 2024	SELL	$14.62 - $18.42 $2.93 Million - $3.7 Million	-200,613 Reduced 3.34%	5,800,790 $94.3 Million
Q1 2024 May 15, 2024	SELL	$17.79 - $30.86 $8.25 Million - $14.3 Million	-463,623 Reduced 7.17%	6,001,403 $111 Million
Q4 2023 Feb 14, 2024	BUY	$20.78 - $31.77 $26 Million - $39.8 Million	1,251,295 Added 24.0%	6,465,026 $202 Million
Q3 2023 Nov 14, 2023	SELL	$20.84 - $33.47 $4.31 Million - $6.91 Million	-206,587 Reduced 3.81%	5,213,731 $109 Million
Q2 2023 Aug 14, 2023	SELL	$17.8 - $25.65 $2.96 Million - $4.27 Million	-166,543 Reduced 2.98%	5,420,318 $130 Million
Q1 2023 May 15, 2023	SELL	$16.32 - $20.92 $35.1 Million - $45.1 Million	-2,153,477 Reduced 27.82%	5,586,861 $105 Million
Q4 2022 Feb 14, 2023	BUY	$14.2 - $18.63 $13.7 Million - $17.9 Million	961,467 Added 14.18%	7,740,338 $123 Million
Q3 2022 Nov 15, 2022	BUY	$14.11 - $18.27 $2.61 Million - $3.38 Million	184,921 Added 2.8%	6,778,871 $111 Million
Q2 2022 Aug 15, 2022	BUY	$13.01 - $27.22 $20 Million - $41.8 Million	1,536,756 Added 30.39%	6,593,950 $92.9 Million
Q1 2022 May 16, 2022	BUY	$20.94 - $27.5 $4.97 Million - $6.52 Million	237,241 Added 4.92%	5,057,194 $122 Million
Q4 2021 Feb 14, 2022	SELL	$16.79 - $27.09 $15.3 Million - $24.6 Million	-908,370 Reduced 15.86%	4,819,953 $112 Million
Q3 2021 Nov 15, 2021	BUY	$15.78 - $24.77 $27.7 Million - $43.5 Million	1,757,712 Added 44.27%	5,728,323 $95.1 Million
Q2 2021 Aug 16, 2021	BUY	$19.4 - $27.42 $14.8 Million - $20.9 Million	761,973 Added 23.75%	3,970,611 $96.8 Million
Q1 2021 May 17, 2021	BUY	$25.02 - $54.99 $15 Million - $32.9 Million	598,812 Added 22.94%	3,208,638 $82.8 Million
Q4 2020 Feb 16, 2021	SELL	$41.04 - $56.79 $3.81 Million - $5.27 Million	-92,758 Reduced 3.43%	2,609,826 $140 Million
Q3 2020 Nov 10, 2020	BUY	$36.42 - $57.0 $4.91 Million - $7.69 Million	134,840 Added 5.25%	2,702,584 $111 Million
Q2 2020 Aug 14, 2020	SELL	$39.26 - $52.73 $57.9 Million - $77.8 Million	-1,474,552 Reduced 36.48%	2,567,744 $124 Million
Q1 2020 May 11, 2020	BUY	$31.65 - $46.87 $128 Million - $189 Million	4,042,296 New	4,042,296 $171 Million

Others Institutions Holding ACAD

# of Institutions

280

Shares Held

156M

Call Options Held

901K

Put Options Held

314K

View Full List

About ACADIA PHARMACEUTICALS INC

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $2.63B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

More about ACAD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Account

State Street Corp Acadia Pharmaceuticals Inc Transaction History